Australia markets open in 7 hours 11 minutes

Scorpius Holdings, Inc. (SCPX)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.1588-0.0010 (-0.63%)
As of 12:31PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.1598
Open0.1606
Bid0.1580 x 1200
Ask0.1588 x 1100
Day's range0.1580 - 0.1649
52-week range0.1400 - 0.8900
Volume107,840
Avg. volume482,467
Market cap5.722M
Beta (5Y monthly)0.10
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date15 Apr 2024 - 21 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University

    DURHAM, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), today announced that it has been awarded a contract in excess of $1 million with an NIH-funded researcher at a major university. The program involves process optimization and development of a therapeutic antibody, which Scorpius will manufacture for preclinical studies. The work will be conducted in the Company’s state-of-the-art

  • GlobeNewswire

    Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium

    Provides Access to Growth Funding and Enhanced Access to Federal ProjectsDURHAM, N.C., March 14, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), today announced that it has been accepted into the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), a part of the National Biopharmaceutical Manufacturing Partnership. The BioMap-Consortium has a $20 billion funding ceiling, throu

  • GlobeNewswire

    Scorpius Holdings, Inc. Announces Closing of Public Offering

    DURHAM, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the closing of its previously announced public offering of 10,000,000 shares of its common stock at a public offering price of $0.15 per share, for gross proceeds of $1,500,000, before deducting underwriting discounts and offering expenses. The Company intends to use the proceeds fr